Loading, please wait....jpg)
.jpg)
The Premier December 21, 2022 CE webinar will be held from 12 - 1 pm EDT. We are pleased to provide one (1) 60-minute knowledge-based, ACPE-accredited CE activity to pharmacists and pharmacy techncians.
UPDATES ON THE USE OF CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPIES IN HEMATOLOGIC MALIGNANCIES
SPEAKER: Brian Primeaux, PharmD, BCOP, Clinical Pharmacy Specialist, Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX
ACPE Universal Activity Number 0122-0000-22-027-L01-T [0.1 CEU] [1 Contact Hr.]
Date: Dec 21, 2022 12:00 PM - 01:00 PM
Fee
CE Hours
CE Units
Registration closes on Dec 21, 2022 12:10 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacy Technicians
Accreditation(s)
|
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Support/Credits
Registration closes on Dec 21, 2022
at 12:10 PM
Registration Closed
Objectives
- Explain the mechanism of action of chimeric antigen receptor (CAR) T-cell therapy in hematologic malignancies
- Recall an indication for CAR T-cell therapy in hematologic malignancies
- Recognize a toxicity associated with CAR T-cell therapy in hematologic malignancies
- Identify a medication used for the management of cytokine release syndrome associated with CAR T-cell therapy
Speaker(s)/Author(s)
|
Brian Primeaux, PharmD, BCOP
|